Does TACROLIMUS Cause Venoocclusive liver disease? 319 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 319 reports of Venoocclusive liver disease have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.4% of all adverse event reports for TACROLIMUS.
319
Reports of Venoocclusive liver disease with TACROLIMUS
0.4%
of all TACROLIMUS reports
133
Deaths
127
Hospitalizations
How Dangerous Is Venoocclusive liver disease From TACROLIMUS?
Of the 319 reports, 133 (41.7%) resulted in death, 127 (39.8%) required hospitalization, and 51 (16.0%) were considered life-threatening.
Is Venoocclusive liver disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 319 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Venoocclusive liver disease?
CYCLOPHOSPHAMIDE (911)
BUSULFAN (765)
FLUDARABINE (649)
VINCRISTINE (616)
METHOTREXATE (590)
CYTARABINE (573)
ETOPOSIDE (523)
OXALIPLATIN (521)
MELPHALAN (464)
DEXAMETHASONE (371)
Which TACROLIMUS Alternatives Have Lower Venoocclusive liver disease Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB